Gideon Mantel of Treato highlights the importance of listening to social media when it comes to patient conversation surrounding clinical trials. When scanning online health discussions ...

has introduced a groundbreaking AI-powered framework designed to transform doctor-patient communication. This innovation addresses critical gaps in clinical documentation, language barriers, and ...

Trump's freeze on federal grants and loans could total trillions of dollars and cause disruptions in health care research, ...

Launay et al compare the persistence of cross-neutralizing antibodies up to 3 months post-booster. The monovalent (MV) recombinant protein Beta-variant (MVB.1.351) vaccine induces higher and ...

Clinical validation of plasma circulating-tumor DNA assay using highly sensitive Safe-SeqS technology for detecting RAS and BRAF V600E in metastatic colorectal cancer. This is an ASCO Meeting Abstract ...

Immutep Limited (IMMP) is a promising biotech stock with a strong pipeline and solid financial foundation, making it a buy ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.

STAT annotates emails physician Kerry Kennedy Meltzer received from her uncle, Robert F. Kennedy Jr., commenting on the ...

Changes in peri-operative chemotherapy and radiation use among patients with resected pancreatic ductal adenocarcinoma (PDAC) between 2004-2021 in the US SEER dataset. This is an ASCO Meeting Abstract ...

The American College of Medical Genetics and Genomics' (ACMG) celebration of this impactful healthcare specialty will unite the entire medical genetics ...

Pegozafermin. It has two Phase 3 trials: one for MASH and the other for SHTG. See why I continue to rate ETNB stock a buy.